In combination with the impossibility of downregulation of insulin secretion in response to a falling plasma glucose level due to a dramatic loss of β-cells [67,68,69,70], an impaired counterregulatory response, in particular glucagon secretion, results in an increase in the incidence of hypoglycemia in T1D patients during the progression of the disease. This evidence concerns the gene INS and Hypoglycemia.